Literature DB >> 18001931

Toric HIFU transducer for large thermal ablation.

David Melodelima1, William A N'Djin, Hubert Parmentier, Michel Rivoire, Jean-Yves Chapelon.   

Abstract

A new geometry of High Intensity Focused Ultrasound (HIFU) transducer is described to enlarge the coagulated volume and decrease treatments time. Eight transducer elements and their quarter-wave plate were diced out of a single toric piezocomposite element. Each transducer operates at a frequency of 3 MHz. The focal zone is conic and located at 70 mm from the transducer. A 7.5 MHz ultrasound imaging probe is placed in the centre of the device for guiding the treatment. Optimal exposure parameters were determined from numerical simulations. This new geometry allows achieving a thermal ablation of 7.5 cm3 when each of the eight transducers has performed a 5-s ultrasound exposure alternatively and consecutively. In vivo trials have been performed on five pigs to demonstrate this new principle. 33 elementary lesions have been performed. All lesions were reproducible and homogeneous. The average diameter of an elementary lesion obtained in 40 seconds was 19.5 +/- 3.8 mm (min 10 - max 29 mm). The coagulated volume obtained in 40 seconds was on average 9.1 +/- 4.6 cm3 (min 1.5 - max 17.6 cm3).

Entities:  

Mesh:

Year:  2007        PMID: 18001931     DOI: 10.1109/IEMBS.2007.4352265

Source DB:  PubMed          Journal:  Annu Int Conf IEEE Eng Med Biol Soc        ISSN: 2375-7477


  2 in total

Review 1.  MR-guided focused ultrasound surgery, present and future.

Authors:  David Schlesinger; Stanley Benedict; Chris Diederich; Wladyslaw Gedroyc; Alexander Klibanov; James Larner
Journal:  Med Phys       Date:  2013-08       Impact factor: 4.071

2.  Efficacy of high-intensity focused ultrasound-assisted hepatic resection (HIFU-AR) on blood loss reduction in patients with liver metastases requiring hepatectomy: study protocol for a randomized controlled trial.

Authors:  Aurélien Dupré; David Pérol; Ellen Blanc; Patrice Peyrat; Valéria Basso; Yao Chen; Jérémy Vincenot; Anthony Kocot; David Melodelima; Michel Rivoire
Journal:  Trials       Date:  2017-02-06       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.